Related Experiment Video
Updated: Aug 9, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
A unique paclitaxel-mediated modulation of the catalytic activity of topoisomerase IIalpha
1Division of Basic Pharmaceutical Sciences, School of Pharmacy, Northeast Louisiana University, Monroe 71209, USA.
Abstract:
Paclitaxel (Taxol) is known to act by polymerizing and stabilizing microtubules. In spite of a known target, the existence of additional targets is suggested by a poor understanding of the mechanism(s) underlying eventual cell death by paclitaxel and by the drug's high efficacy, as compared to other spindle poisons. Based on the enhanced sensitivity of a mutant DNA double-strand break repair-deficient Chinese hamster ovary cell line to paclitaxel as well as to various topoisomerase (Topo) II poisons, it was hypothesized that paclitaxel, in addition to having an effect on microtubules, may also alter the activity of Topo II. This study demonstrates the unique, in vitro effects of paclitaxel on Topo II activity as investigated by monitoring the decatenation of kinetoplast DNA and relaxation of supercoiled plasmid DNA by Topo II. Unlike classical anti-topoisomerase drugs, low concentrations of paclitaxel (0.02-500 nM) stimulated Topo II catalytic activity, while higher concentrations over 5 microM inhibited the activity of Topo II. Furthermore, these effects of paclitaxel appear to be mediated through a direct interaction of paclitaxel with Topo II rather than an interaction with DNA or DNA-Topo II complexes. Collectively, the evidence presented suggests the existence of an atypical interaction between Topo II and paclitaxel that may disrupt the normal functioning of the enzyme.
Insights
Paclitaxel (Taxol) may target more than microtubules. This study shows paclitaxel directly interacts with topoisomerase II (Topo II), uniquely stimulating or inhibiting its activity, suggesting a novel mechanism of action for this cancer drug.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Paclitaxel (Taxol) is a microtubule-stabilizing agent used in cancer therapy.
- Its precise mechanisms of cell death and high efficacy suggest potential additional molecular targets beyond microtubules.
- Enhanced sensitivity of DNA repair-deficient cells to paclitaxel and Topo II poisons prompted investigation into paclitaxel's interaction with Topo II.
Purpose of the Study:
- To investigate the hypothesis that paclitaxel alters topoisomerase II (Topo II) activity.
- To characterize the in vitro effects of paclitaxel on Topo II catalytic function.
Main Methods:
- Assessed Topo II activity by monitoring kinetoplast DNA decatenation and supercoiled plasmid DNA relaxation.
- Examined the effects of varying paclitaxel concentrations on Topo II enzymatic activity.
- Investigated whether paclitaxel interacts directly with Topo II, DNA, or DNA-Topo II complexes.
Main Results:
- Low concentrations of paclitaxel (0.02-500 nM) stimulated Topo II catalytic activity.
- High concentrations of paclitaxel (over 5 microM) inhibited Topo II activity.
- Paclitaxel's effects on Topo II activity appear to result from direct interaction with the enzyme, not DNA or DNA-Topo II complexes.
Conclusions:
- Paclitaxel exhibits unique, concentration-dependent effects on Topo II activity, distinct from classical Topo II poisons.
- Evidence suggests a direct interaction between paclitaxel and Topo II.
- This atypical interaction may contribute to paclitaxel's overall mechanism of action and efficacy in cancer treatment.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Drugs that Destabilize Microtubules

